ArticleAdvances in therapy2023

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics.

Martin Kolb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.